Two Device Industry Veterans Join Boston Scientific’s Board
This article was originally published in The Gray Sheet
Executive Summary
Hologic CEO Stephen MacMillan and former Covidien exec Charles Dockendorff have been elected to Boston Scientific’s board of directors, adding significant device industry expertise to the mix. MacMillan will be the only active device industry CEO for another company on the board.